Changes in HER2 Testing in Breast Cancer Following the 2013 Update to the ASCO/CAP Recommendations
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Comparative Analysis of Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer According to 2007 and 2013 American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations
J. Clin. Oncol 2017 Apr 26;[EPub Ahead of Print], WM Hanna, E Slodkowska, FI Lu, H Nafisi, S Nofech-MozesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.